Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 3, 2023. (Total: 223614Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Achievement and CYP2C9[original query]
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
Arthritis and rheumatism 2004 Jul 50 (7): 2202-10.
Takada Kazuki, Arefayene Million, Desta Zeruesenay, Yarboro Cheryl H, Boumpas Dimitrios T, Balow James E, Flockhart David A, Illei Gabor
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.
Blood 2011 Sep 118 (11): 3163-71.
Gong Inna Y, Tirona Rommel G, Schwarz Ute I, Crown Natalie, Dresser George K, Larue Samantha, Langlois Nicole, Lazo-Langner Alejandro, Zou Guangyong, Roden Dan M, Stein C Michael, Rodger Marc, Carrier Marc, Forgie Melissa, Wells Philip S, Kim Richard
Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial.
Trials 2012 Dec 13 (1): 1.
Carcas AJ, Borobia AM, Velasco M, Abad-Santos F, Díaz MQ, Fernández-Capitán C, Ruiz-Giménez N, Madridano O, Sillero PL
The impact of the CYP2C9 and VKORC1 polymorphisms on acenocoumarol dose requirements in a Romanian population.
Blood cells, molecules & diseases 2012 Nov .
Buzoianu AD, Militaru FC, Vesa SC, Trifa AP, Cri?an S
Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.
European journal of clinical pharmacology 2016 Nov 72 (11): 1327-1334.
Zeng Wu-Tao, Xu Qing, Li Cheng-Hsun, Chen Wei-Yan, Sun Xiu-Ting, Wang Xiang, Yang Yi-Ying, Shi Hui, Yang Zhi-She
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.
Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423.
Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav
Genetic contribution to lipid target achievement with statin therapy: a prospective study.
The pharmacogenomics journal 2019 Dec .
Ruiz-Iruela Cristina, Candás-Estébanez Beatriz, Pintó-Sala Xavier, Baena-Díez Neus, Caixàs-Pedragós Assumpta, Güell-Miró Roser, Navarro-Badal Rosa, Calmarza Pilar, Puzo-Foncilla Jose Luis, Alía-Ramos Pedro, Padró-Miquel Ariad
TOP